Captozyme Opens Up New Headquarters
After graduating from the University of Florida's Innovation Hub, biotechnology company Captozyme bought their new headquarters in Gainesville, FL.
Gainesville, FL, April 20, 2017 --(PR.com)-- Upon graduating from the University of Florida’s Innovation Hub, local biotechnology company, Captozyme Inc., recently acquired a newly constructed facility to house their new headquarters at 1622 NW 55th Place. The company plans to consolidate all operations there during the coming months, and is proud to be part of the developing biotechnology scene of Gainesville.
“Settling down in Gainesville is a natural next step in our vision,” said Helena Cowley, Captozyme CEO. “We owe so much of our success to the local community; entrepreneurs, mentors, and particularly the University of Florida Incubators. We are excited to continue growing with the biotech community here.”
The new facility has 7500 sq. ft. of laboratory/office space and will have nearly 1000 sq. ft. of cGMP compliant manufacturing suites for the fermentation and drying of microbiota organisms. Once all moved in, the new headquarters will house 20 employees, though Captozyme is looking to increase this number in the coming months. Good news for other up-and-coming start-up companies is that Captozyme’s graduation from the Innovation Hub frees up space in this growing incubator.
Jane Muir, Director of the Innovation Hub, commented, “Being able to provide the resources and expertise offered by the Innovation Hub early in a company’s formation can significantly impact their likelihood of success. Captozyme is a wonderful example of that and is exactly the type of success story we want to replicate over and over again in our community.”
Thanks to the effort in the recent years by the University of Florida and the innovation square, Gainesville is quickly becoming a popular destination for developing biotechnology companies. Captozyme is excited to be part of this growing scientific hub and can’t wait to see how the new attention will invigorate the local community.
About Captozyme, Inc.
Captozyme, Inc. is a biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch NephureTM in the spring of 2017. With Nephure the company has created a product that allows people to enjoy the foods they love without the consequences of adding oxalate to their body. Captozyme also serves the industry by furthering process development and manufacturing in the field of anaerobic organisms. Learn more about Captozyme at Captozyme.com or visit Nephure.com.
About the Innovation Hub at the University of Florida
The Innovation Hub is a unique, all-inclusive incubator designed to provide an innovation ecosystem that can significantly impact the success of early-stage companies by “creating collision” among members, partners, visitors, and the general community. The Innovation Hub brings together the public and private sector to provide a wealth of resources for startups of varying stages, including resources, expertise, and programming. The Innovation Hub at the University of Florida is open to both entrepreneurs affiliated with the University and also in the broader community. Learn more at http://floridainnovationhub.ufl.edu/
“Settling down in Gainesville is a natural next step in our vision,” said Helena Cowley, Captozyme CEO. “We owe so much of our success to the local community; entrepreneurs, mentors, and particularly the University of Florida Incubators. We are excited to continue growing with the biotech community here.”
The new facility has 7500 sq. ft. of laboratory/office space and will have nearly 1000 sq. ft. of cGMP compliant manufacturing suites for the fermentation and drying of microbiota organisms. Once all moved in, the new headquarters will house 20 employees, though Captozyme is looking to increase this number in the coming months. Good news for other up-and-coming start-up companies is that Captozyme’s graduation from the Innovation Hub frees up space in this growing incubator.
Jane Muir, Director of the Innovation Hub, commented, “Being able to provide the resources and expertise offered by the Innovation Hub early in a company’s formation can significantly impact their likelihood of success. Captozyme is a wonderful example of that and is exactly the type of success story we want to replicate over and over again in our community.”
Thanks to the effort in the recent years by the University of Florida and the innovation square, Gainesville is quickly becoming a popular destination for developing biotechnology companies. Captozyme is excited to be part of this growing scientific hub and can’t wait to see how the new attention will invigorate the local community.
About Captozyme, Inc.
Captozyme, Inc. is a biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch NephureTM in the spring of 2017. With Nephure the company has created a product that allows people to enjoy the foods they love without the consequences of adding oxalate to their body. Captozyme also serves the industry by furthering process development and manufacturing in the field of anaerobic organisms. Learn more about Captozyme at Captozyme.com or visit Nephure.com.
About the Innovation Hub at the University of Florida
The Innovation Hub is a unique, all-inclusive incubator designed to provide an innovation ecosystem that can significantly impact the success of early-stage companies by “creating collision” among members, partners, visitors, and the general community. The Innovation Hub brings together the public and private sector to provide a wealth of resources for startups of varying stages, including resources, expertise, and programming. The Innovation Hub at the University of Florida is open to both entrepreneurs affiliated with the University and also in the broader community. Learn more at http://floridainnovationhub.ufl.edu/
Contact
Captozyme
Helena Cowley
352-363-2917
www.captozyme.com/
Helena Cowley
352-363-2917
www.captozyme.com/
Contact
Categories